[1] Wolfgang A.G. Sauerwein and Ray L. Moss. “Requirements for Boron Neutron Capture Therapy (BNCT) at a nuclear research reactor”. European Communities , (2009) pp 125.
[2] B.Shapiro,S.Kulkarni,A.Nacev,S.Muro,P.V.Stepanov and I.N.Weinberg “Open challenges in magnetic drug targeting",WIRES Nanomedicine and Nanobiotechnology (2014).
[3] Veiseh O. Gunn J.W., Zhang M., “Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging”, Adv. Drug Deliv. Rev., 62 (2010) 284–304.
[4] A. Nacev, C. Beni, O. Bruno, B. Shapiro, “The behaviors of ferromagnetic nano-particles in and around blood vessels applied under magnetic fields”. Journal of magnetism and magnetic material 323 (2011) 651-668.
[5] E. M. Cherry, J. K. Eaton, A comprehensive model of magnetic particle motion during magnetic drug targeting, International Journal of Multiphase Flow, Vol. 59 (2014) pp.173-185.
[6] B. Gleich, N. Hellwig, H. Bridell, R. Jurgons, C. Seliger, C. Alexiou, B. Wolf, T. Weyh, “Design and evaluation of magnetic fields for nanoparticle drug targeting in cancer” IEEE Transactions on nanotechnology Vol. 6 (2007) 164-170.
[7] CST STUDIO SUITE users Manual ;See also www.cst.
[8] A. Nacev, I. N. Weinberg, P. Y. Stepanov, S. Kupfer, L. O. Mair, M. G. Urdaneta, M. Shimoji, zS. T. Fricke, and B. Shapiro “Dynamic Inversion Enables External Magnets To Concentrate Ferromagnetic Rods to a Central Target”. Nano Lett. 15 (2014) 359-364.
)